Brigit Biofarmaka Teknologi Tbk. vs Prodia Widyahusada Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Prodia Widyahusada Tbk. trades at Rp2,390 (market cap 2.24T, 561.6K 24h volume). The key difference: Prodia Widyahusada Tbk. is far larger — about 13× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 561.6K). Which is the better fit depends on your goals.
| OBAT | PRDA | |
|---|---|---|
Market Cap | 172.82B | 2.24T |
Volume | 592.2K | 561.6K |
Lot | 5.92K | 5.62K |
Turnover | 147.05M | 1.34B |
Average Price | 248.31 | 2,391.24 |
Value | 147.05M | 1.34B |
Indicative Equilibrium Price | 254 | 2,390 |
Indicative Equilibrium Volume | 10 | 191 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Prodia Widyahusada Tbk (the Company) was established based on the Deed of Notary Sri Rahayu, SH, No. 14 dated February 8, 1988. Clinical Laboratory Prodia was first established in Solo, Central Java, on May 7, 1973 by a few idealists pharmaceutical educational background.
Read more on PRDA →